Notice of annual general meeting of Calliditas Therapeutics AB (publ)

STOCKHOLM, April 28, 2023 /PRNewswire/ -- The shareholders of Calliditas Therapeutics AB (publ) ("Calliditas Therapeutics"), Reg. No. 556659-9766, with registered office in Stockholm, are summoned

Related Keywords

Stockholm ,Sweden ,United States ,American ,Swedish ,Jakob Grunditz ,Alfred Driscoll ,Fredrik Johansson ,Monte Carlo ,Molly Henderson ,Elmar Schnee ,Henrik Stenqvist ,Stiftelsen Industrifonden ,Patrik Sobocki Stiftelsen Industrifonden ,Hilde Furberg ,European Commission ,Remuneration Committee ,European Union Member States ,Oxigene Inc ,Swedish Companies Registration Office ,Bentley University ,Swedish Bar Association ,Swedish Companies ,Calliditas Therapeutics ,Euroclear Sweden ,Karl Tobieson ,Patrik Sobocki ,Diane Parks ,Flexion Theraputics ,Calliditas Therapeutic ,Swedish Code ,Nasdaq Stockholm ,Main Shareholders ,Share Awards ,Vesting Date ,Grant Date ,Share Award ,Swedish Companies Act ,American Depositary Shares ,Nasdaq Global Select Market ,Notice ,Nnual ,Eneral ,Meeting ,Calliditas ,Herapeutics ,Publ ,